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http:WHAT THIS PAPER ADDS
This study showed that the POSSUM physiology score (PPS) can be used as an indicator of long-term survival of
vascular surgery patients. In addition, stratiﬁcation of low- and high-risk patients showed a statistically signif-
icant difference in all-cause mortality outcomes (median 17 months survival for high-risk patients versus
70 months for low-risk patients). These two newly identiﬁed characteristics of PPS in vascular patients should be
of value for surgical management.Objectives:We investigated whether the POSSUM physiology score, originally designed as an indicator for 30-day
mortality for comparative audit, could be used as an indicator of long-term survival in vascular surgery practice.
Methods: Data from 184 different vascular procedures conducted between 1989 and 2000, containing survival
data for each patient of 10 years or longer, were analysed retrospectively. Parameters collected were the pre-
operative physiological and the operative severity POSSUM score, gender, and type of procedure. Multivariate
analyses were performed using Cox regression method and, on the basis of their physiological POSSUM score
grouping, KaplaneMeier analysis was performed for estimation of overall survival.
Results: Both an increase in physiological POSSUM score (hazard ratio [HR] 1.050, 95% conﬁdence interval [CI]
1.031 to 1.070) and one of its components, age (HR 1.025, 95% CI 1.006 to 1.045; p ¼ 0.009), were shown to be
indicators of long-term all-cause mortality. The sample’s mean physiological POSSUM score of 21 was then used as
a cut-off point to categorise low and high-risk vascular surgery patients. Median survival in the low-risk group was
70 months (95% CI 56e86 months), whereas in the high-risk group this was 17 months (95% CI 3e31 months).
Conclusion: The physiological POSSUM score, including patient age, is an indicator of long-term survival of
patients with vascular disease. This may help in choosing the appropriate vascular intervention.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The physiological and operative severity score for
enumeration of mortality and morbidity (POSSUM) is a
scoring system that allows prediction of perioperative
mortality and morbidity in general surgical patients.1 POS-
SUM was originally developed for comparative audit pur-
poses.2,3 A number of similar risk-scoring tools have been
devised and evaluated over the years, with POSSUM
consistently performing well when used for vascularrresponding author. North Cumbria University Hospitals NHS Trust,
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//dx.doi.org/10.1016/j.ejvs.2013.05.018surgery patients.4 Subsequent observations on orthopaedic
and colorectal cancer patients demonstrated that POSSUM
also predicted long-term overall survival.5,6 The BASIL trial
suggested that an endovascular-ﬁrst approach would suit
vascular patients with short life expectancy whereas a
bypass-ﬁrst approach would be of beneﬁt in patients who
were going to live longer.7 An endovascular-ﬁrst approach
may be advisable in patients with signiﬁcant comorbidity,
whereas for ﬁt patients with a longer-term perspective a
bypass procedure may be offered as a ﬁrst-line interven-
tional treatment.8
A system to predict long-term survival could potentially
guide vascular surgeons to tailor treatments better to pa-
tients of different risk categories. This may apply to aneu-
rysm management as well due to the differences in
durability of the two approaches, with endovascular surgery
requiring more secondary interventions in the long term.9,10
The primary objective of this study was therefore to eval-
uate any potential relation between the POSSUM score
Table 1. Types of vascular surgery performed.
Surgical procedure category Patients, n (%)
Femoropopliteal bypass 47 (26%)
Other femoral surgery 40 (22%)
Endarterectomy 26 (14%)
Other amputations 16 (9%)
Embolectomy 15 (8%)
Below knee amputation 13 (7%)
Sympathectomy 11 (6%)
Above knee amputation 8 (4%)
Angioplasty 5 (3%)
Aortic aneurysm repair 3 (2%)
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with vascular disease.METHODS
POSSUM scoring system
The POSSUM scoring system was developed in the late
1980s from the need for a simple scoring system that could
be used across the general surgical spectrum to compare
the outcomes between different units. At the outset the
developers started with 62 variables from standard surgical
practice and analysed their relevance by multivariate anal-
ysis. Point value on an exponential score (1, 2, 4 or 8) was
assigned after dividing the multivariate discriminant func-
tion coefﬁcients of the relevant factors by a constant, and
rounding them to the nearest whole number. Of the original
variables, the 12 ﬁnal clinical features that are scored for
the POSSUM physiology score (PPS) are age, cardiac signs,
chest radiograph, respiratory signs, systolic blood pressure,
pulse rate, coma score, serum urea/Na/K, haemoglobin
level, white blood cell count, and electrocardiogram (total
score range is 12e96).1 The components of the operative
severity POSSUM (OSP) score include magnitude, number of
operations within 30 days, intraoperative blood loss,
contamination, presence of malignancy, and timing of
operation (total score range is 6e48).1 Since its introduction
in the early 1990s, various groups have sought to further
optimise POSSUM and to tailor it to speciﬁc disease areas,
including vascular surgery.11 However, the original generic
POSSUM is probably still the tool that is in widest use, is
relevant to vascular surgery,12 and was therefore an
appropriate tool to evaluate in relation to long-term overall
survival.Table 2. Cox multivariate and univariate regression analysis of patient
Variable Multivariate
Hazard ratio (95% CI) p
Age 1.025 (1.006 to 1.045)
PPS 1.050 (1.031 to 1.070) <
OSP score 0.937 (0.881 to 0.996)
Gender 1.072 (0.759 to 1.513)
Amputation status 0.866 (0.547 to 1.371)
CI ¼ conﬁdence interval.Patients
A total of 184 vascular patients operated between 1989 and
2000 in our district general hospital had their physiological
parameters prospectively collected using a pro forma; A
retrospective study was conducted on the anonymised
data. Data collected as part of the analysis included patient
age and gender, PPS, OSP score (for 160 out of 184 pa-
tients), date and type of operation, follow-up period and
alive/deceased status up to 31 December 2009.Statistical analysis
Data were collated in Microsoft Excel 2007, and further
analysed and interpreted using SPSS Statistical Package for
Social Sciences (SPSS) version 17.0 (SPSS Inc. Chicago, IL,
USA, 2007). Cox multivariate and univariate regression
analysis and Spearman correlation coefﬁcient analysis
were performed for the complete sample, whereas
KaplaneMeier survival curves, log-rank test (survival) and
Student t-test (age) were applied to the low and high PPS
groups.
RESULTS
The average age for the 184 patients at their ﬁrst operation,
that is start of data recording, was 71 years, with a median
of 72 years (minimum age 44 years and maximum age 93
years). Males accounted for 61% of the cohort, and 39%
were females. The longest follow-up for one of the patients
was 246 months, whereas the mean follow-up for all pa-
tients was 60 months (median 42 months). Twenty of the
184 patients, 11%, were alive on the last follow-up date,
which was 31 December 2009. Table 1 shows a summary of
the procedures these patients underwent. Bypass surgery
and amputations were the most common among them.
The relationship between age, PPS, OSP score, gender
and amputation status were ﬁrst investigated by Cox
multivariate regression analysis. Neither patient gender nor
operations involving amputations had a statistically signiﬁ-
cant impact on long-term all-cause mortality in this sample;
only amputation was signiﬁcantly associated with all-cause
mortality in univariate regression analysis. Increased age
and PPS correlated with increased all-cause mortality;
conversely, a higher OSP score correlated with decreased
long-term all-cause mortality (Table 2). Univariate correla-
tion analysis conﬁrmed the data obtained in Cox regression
analysis. There was signiﬁcant inverse correlation between
PPS and survival time, indicating that an increased PPSsurvival.
Univariate
-Value Hazard ratio (95% CI) p-Value
0.009 1.040 (1.022 to 1.057) <0.001
0.001 1.059 (1.043 to 1.075) <0.001
0.037 0.931 (0.879 to 0.986) 0.015
0.693 1.118 (0.869 to 1.626) 0.281
0.540 1.664 (1.111 to 2.492) 0.014
Table 3. Number of patients with low and high POSSUM physiological score and survival rates.
Patients, n Age in yrs,
mean
Deceased, n (%) Alive, n (%) Median survival
(months)
Survival 95% CI
(months)
Low PPS 109 68 92 (84%) 17 (16%) 70 56 to 86
High PPS 75 71 72 (96%) 3 (4%) 17 3 to 31
Overall 184 71 164 (89%) 20 (11%) 40 25 to 55
I. Sohail et al. 225increased the mortality. The Spearman’s rho correlation
coefﬁcient was .508 (p < 0.001). In comparison, age by
itself also correlated with survival, but to a lesser degree
than PPS. The Spearman rho correlation coefﬁcient for age
was 0.323 (p <0.001). OSP score on the other hand,
correlated positively with survival albeit very moderately
(Spearman rho 0.053, p < 0.001).
The mean PPS for the cohort was 21.45; therefore a score
of 21 was taken as the cut-off point between low- (up to
and including 21) and high-risk (22 and above) vascular
surgery patients. On average, the patients in the low PPS
group were signiﬁcantly younger than those in the high PPS
group, mean 68 years versus 71 years (t-test p < 0.001), see
Table 3. This equates to a point score difference of 2 when
using PPS. The survival times also differed signiﬁcantly (log-
rank test, p <0.001) between the low- and high-risk pa-
tients. Median difference in survival time was 53 months,
and 95% of all high-risk patients do not survive beyond 31
months. Only 3 out of 75 (4%) patients survived this follow-
up period; these high-risk patients were followed up for
130, 136 and 140 months respectively. Fig. 1 shows a
KaplaneMeier survival analysis for all patients, stratiﬁed by
low- and high-risk PPS. The observed effect was consistent
whether one included 30-day mortality or not, but the
illustration shows the result with all mortality included. The
survival curves start to converge at 100 months but are
particularly different at month 50.Numbers at risk
Low PPS 109 91 87 76 69 64 53
High PPS 75 40 34 22 18 16 14
Figure 1. POSSUM score and relationship with survival of patients.DISCUSSION
This study shows that a vascular patient’s pre-operative
condition, measured by PPS, can predict their overall sur-
vival. On the other hand, a very limited positive, probably
non-attributable, correlation was found between OSP score
and long-term overall survival. Similar observations were
made by Back et al. in 2004.13 Age is a parameter in PPS and
is already known to be a risk factor for mortality within 30
days of vascular surgery, for example in aortic procedures,
and has also been shown to be an independent risk factor
for long-term mortality in vascular surgery.13,14 In this study,
however, the higher correlation coefﬁcient for PPS than for
age indicates that PPS has a stronger correlation with long-
term overall survival of patients. The correlation between
cardiac status and survival has already been shown.13 The
reason for convergence of the Kaplan Meier curves at 100
months is not clear but may reﬂect the changing physiology
with time. Stratiﬁcation of the PPS into a low- and high-risk
group of patients to compare the long-term overall survival
has been applied previously for colorectal cancer patients
and orthopaedic patients.5,6 Brosens et al.5 also used the
mean PPS, without the age component, to discriminate
between low- and high-risk groups. The clinical parameters
included in PPS are routinely collected in everyday practice
and were considered to be easy to use for even the non-
specialists.1 Our cohort of patients included a variety of
vascular conditions reﬂecting the spectrum of conditions
usually met in vascular practice. Therefore we believe that
the above ﬁnding may potentially help vascular surgical
practice in general.
The expansion of endovascular devices and imaging ca-
pabilities has opened a variety of new minimally invasive
techniques to treat vascular patients.The BASIL trial looked at
endovascular-ﬁrst and surgery-ﬁrst strategies and concluded
that there was no signiﬁcant difference between the two
strategies in terms of overall survival or amputation-free
survival except in patients who survived beyond 2 years after
the intervention.14,15 For those patients who survived for at
least 2 years after randomisation, a bypass-ﬁrst revascular-
isation strategy was associated with a signiﬁcant increase in
subsequent overall survival and a trend towards improved
amputation-free survival.14,15 This ﬁnding started the quest
to ﬁnd a predictor for survival in vascular patients, and this
has been shown to have cost implications too.16,17 A recent
critical appraisal suggested that any thoughtful review of the
available data leads one to the conclusion that neither an
“endo-ﬁrst” nor a “bypass-ﬁrst” dogma is an appropriate
technique in patients with critical limb ischaemia.18 Man-
agement of abdominal aortic aneurysms also faces similar
issues.
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have sought to further optimise POSSUM and to tailor it to
speciﬁc specialty areas, including vascular surgery.11 How-
ever, the original generic POSSUM is probably still the tool
that is in widest use and is relevant to vascular surgery.12
The scoring is simple and uses only routine parameters,
making it easier for daily practice to guide vascular surgeons
to tailor the treatment options to patients of different
categories. In conclusion, this study shows that the PPS,
rather than the OSP score, can potentially be used as an
indicator of a patient’s long-term survival. As a component
of PPS, age contributes to this too. PPS can therefore play a
role when risk-stratifying a patient as part of their surgical
management.
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